Federal contractor · PARSIPPANY, NJ

FERRING PHARMACEUTICALS INC

FERRING PHARMACEUTICALS INC received $45.8K in federal contract obligations in FY2026, on 1 awards (0% vs FY2025). Since FY2024: $504.1K. Its largest customer was Department of Veterans Affairs ($45.8K).

Obligations · FY2026: $45.8K
New awards: 1
Sole-source: 0.0%
Single offer: 100%

UEI: D6ATBE6Y96L5
Parent company: FERRING HOLDING S.A.

Other than small business

Open in the contracts explorer Relationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

412.5KFY2024
45.8KFY2025
45.8KFY2026

Top buying agencies

Obligations in FY2026.

Department of Veterans Affairs$45.8K100%
1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$45.8K100%

Where the work was performed

Denton County, TX$45.8K100%

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition100%
US 39% · $45.8K
Sole-source awards0.0%
US 30% · $0
Single-offer competitions100%
US 8.8% · $45.8K
Urgency justifications0.0%
US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

ADSTILADRIN (NADOFARAGENE FIRADENOVEC)$45.8K
Department of Veterans Affairs· Denton County, TX· Health & medical· Oct 17, 2025 – Oct 17, 2025· 36C24526N0103

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

ANNOVEX PHARMA INC$500K
LORTON, VA · 99% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
PHARMALOGIC LTD$513.4K−128% in FY2026
WILLISTON, VT · 100% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
APL SALES I LLC$490.3K−100% in FY2026
WALTHAM, MA · 97% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

Ferring Pharmaceuticals Inc.AI match · 100%

Lobbying · 2025: $770K; 21 reports
Lobbying · 2023–2026: $2.7M; $2.7M in its own reports

Lobbying by year

2023$890K
30 reports
2024$610K
21 reports
2025$770K
21 reports
2026$470K
10 reports

Top issues

Health issues59 reports
Veterans10 reports
Taxation and the Internal Revenue Code6 reports
Trade (domestic and foreign)6 reports
Defense3 reports
Miscellaneous tariff bills3 reports
Budget and appropriations2 reports

Who was contacted

U.S. HOUSE OF REPRESENTATIVES58 reports
U.S. SENATE54 reports
Health & Human Services - Dept of (HHS)14 reports
Executive Office of the President (EOP)8 reports
Commerce - Dept of (DOC)7 reports
U.S. Trade Representative (USTR)6 reports
White House Office6 reports
Office of Personnel Management (OPM)2 reports
Bureau of Industry and Security (BIS)1 reports
Veterans Affairs - Dept of (VA)1 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Baker & Hostetler LLP$720K
12 reports
Brownstein Hyatt Farber Schreck, LLP$680K
13 reports
Todd Strategy Group$550K
11 reports
Pillsbury Winthrop Shaw Pittman LLP$300K
5 reports
BALLARD PARTNERS$290K
3 reports
The Madison Group$166K
4 reports
PRIME POLICY GROUP$100K
3 reports
HillStaffer, LLC$0
14 reports

9 firms in all. Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 7, 2026, loaded Oct 7, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 8, 2026, loaded Oct 8, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Bills named in its lobbying reports

H.R. 1878 · IVF Access and Affordability Act6 reports
119th Congress · Introduced · 2025–2026
H.R. 2670 · National Defense Authorization Act for Fiscal Year 20244 reports
118th Congress · Became law · 2023–2024
H.R. 2828 · Family Building FEHB Fairness Act4 reports
118th Congress · Introduced · 2023–2024
H.R. 3305 · Black Maternal Health Momnibus Act4 reports
118th Congress · Introduced · 2023–2024
H.R. 3503 · NIH Clinical Trial Diversity Act of 20234 reports
118th Congress · Introduced · 2023–2024
H.R. 3838 · Preventing Maternal Deaths Reauthorization Act of 20234 reports
118th Congress · Passed one chamber · 2023–2024
H.R. 4363 · Comprehensive Cancer Survivorship Act4 reports
118th Congress · Introduced · 2023–2024
H.R. 4731 · Access to Infertility Treatment and Care Act4 reports
118th Congress · Introduced · 2023–2024
H.R. 544 · Veterans Infertility Treatment Act of 20234 reports
118th Congress · Introduced · 2023–2024
H.R. 5492 · Veteran Families Health Services Act of 20234 reports
118th Congress · Introduced · 2023–2024

10 of 82 reports (2023–2026) name at least one bill. Bills and resolutions the current reports name in their issue descriptions, by number of reports. A report names what it lobbied on, not which side it took.

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 8, 2026, loaded Oct 8, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 7, 2026, loaded Oct 7, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.